IWM
VRNA

IHT Wealth Management’s Verona Pharma VRNA Stock Holding History

IHT Wealth Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,560
Closed -$102K – 857
2021
Q3 		$102K Hold
18,560
– – 0.01% 774
2021
Q2 		$121K Sell
18,560
-130
-0.7% -$901 0.01% 901
2021
Q1 		$156K Buy
18,690
+130
+0.7% +$1.08K 0.01% 792
2020
Q4 		$130K Sell
18,560
-3,200
-15% -$21.6K 0.01% 710
2020
Q3 		$136K Hold
21,760
– – 0.01% 618
2020
Q2 		$102K Hold
21,760
– – 0.01% 560
2020
Q1 		$90K Buy
21,760
+1,300
+6% +$7.13K 0.01% 513
2019
Q4 		$118K Hold
20,460
– – 0.01% 594
2019
Q3 		$94K Buy
20,460
+3,130
+18% +$14K 0.01% 586
2019
Q2 		$88K Hold
17,330
– – 0.01% 524
2019
Q1 		$113K Buy
+17,330
New +$113K 0.02% 489

Other funds holding VRNA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

IHT Wealth Management's VRNA Position: Q4 2021 in Review

IHT Wealth Management sold out of Verona Pharma (VRNA) in Q4 2021, closing a stake of 18,560 shares — an estimated $102K sold.

IHT Wealth Management first reported a position in VRNA in Q1 2019 and held it in 11 quarters. The position peaked at $156K in Q1 2021. 42 funds tracked by Wall St. Rank hold VRNA as of Q4 2021.

  • IHT Wealth Management reported no remaining Verona Pharma position as of Q4 2021 after selling out during the quarter.
  • IHT Wealth Management sold 18,560 Verona Pharma shares in Q4 2021, an estimated $102K.
  • IHT Wealth Management first reported a position in Verona Pharma in Q1 2019 and held it in 11 quarters.
  • IHT Wealth Management's Verona Pharma position peaked at $156K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Verona Pharma as of Q4 2021.

Based on IHT Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.